KRAS and BRAF Mutations in 203 Esophageal Squamous Cell Carcinomas: Pyrosequencing Technology and Literature Review

BACKGROUND: Epidermal growth factor receptor (EGFR) signaling is one of the most promising targets for molecular-targeted therapies in esophageal squamous cell carcinoma (ESCC). Thus, the molecular diagnosis of KRAS and BRAF mutations is clinically important in therapeutic decision making. However,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Shigaki, Hironobu, Baba, Yoshifumi, Watanabe, Masayuki, Miyake, Keisuke, Murata, Asuka, Iwagami, Shiro, Ishimoto, Takatsugu, Iwatsuki, Masaaki, Yoshida, Naoya, Baba, Hideo
Format: Artigo
Idioma:Inglês
Publicat: Springer US 2012
Matèries:
Translational Research and Biomarkers
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3853643/
https://ncbi.nlm.nih.gov/pubmed/23274581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-012-2819-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars